Analysts’ Upgrades for November 19th (BGMS, CURB, ELAN, FCX, JHX, LAC, LZB, PVLA, RLMD, TU)

Analysts’ upgrades for Wednesday, November 19th:

Cyclacel Pharmaceuticals (NASDAQ:BGMS) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Curbline Properties (NYSE:CURB) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. Citigroup Inc. currently has $27.00 target price on the stock, up from their previous target price of $25.00.

Elanco Animal Health (NYSE:ELAN) was upgraded by analysts at Argus from a hold rating to a buy rating. They currently have $25.00 price target on the stock.

Freeport-McMoRan (NYSE:FCX) was upgraded by analysts at Clarkson Capital from a neutral rating to a buy rating. They currently have $46.00 price target on the stock.

James Hardie Industries (NYSE:JHX) was upgraded by analysts at Vertical Research from a hold rating to a buy rating. Vertical Research currently has $21.00 price target on the stock.

Lithium Americas (NYSE:LAC) was upgraded by analysts at Canaccord Genuity Group Inc. from a sell rating to a hold rating.

La-Z-Boy (NYSE:LZB) was upgraded by analysts at Sidoti from a neutral rating to a buy rating. The firm currently has $39.00 target price on the stock, up from their previous target price of $36.00.

Palvella Therapeutics (NASDAQ:PVLA) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. The firm currently has $143.00 price target on the stock, up from their previous price target of $92.00.

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. They currently have $10.00 price target on the stock, up from their previous price target of $1.00.

TELUS (NYSE:TU) (TSE:T) was upgraded by analysts at National Bank Financial from a sector perform rating to an outperform rating.

Urban Outfitters (NASDAQ:URBN) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

WESCO International (NYSE:WCC) was upgraded by analysts at Royal Bank Of Canada from a sector perform rating to an outperform rating. They currently have $302.00 price target on the stock, up from their previous price target of $262.00.

Zions Bancorporation, N.A. (NASDAQ:ZION) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. The firm currently has $60.00 price target on the stock, up from their previous price target of $55.00.

Receive News & Ratings for Cyclacel Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.